表紙
市場調査レポート

臨床化学分析装置市場:製品別(システムおよび試薬)、検査種類別(基礎代謝、電解質、肝臓、脂質、腎臓、甲状腺機能、特殊化学物質)、エンドユーザー別(病院、試験所、学術研究機関)-2019年までの世界市場予測

Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019

発行 MarketsandMarkets 商品コード 318269
出版日 ページ情報 英文 195 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
臨床化学分析装置市場:製品別(システムおよび試薬)、検査種類別(基礎代謝、電解質、肝臓、脂質、腎臓、甲状腺機能、特殊化学物質)、エンドユーザー別(病院、試験所、学術研究機関)-2019年までの世界市場予測 Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019
出版日: 2014年10月22日 ページ情報: 英文 195 Pages
概要

世界の臨床化学分析装置市場は2014年に89億6,500万米ドル規模となり、今後2014〜2019年にかけCAGR5.52%で拡大するとみられ、2019年には117億2,801万米ドルに達する見込みです。診断薬市場の急速な発展、医療費の高騰、生活習慣病の発症率上昇などが市場の拡大を牽引しています。さらに予防医療への意識拡大や高齢化、試薬レンタル契約、試験所自動化の需要拡大なども臨床化学分析装置の需要拡大の一助となっています。

当レポートでは、臨床化学分析装置市場について分析し、製品別、検査種類別、エンドユーザー別の動向、将来的見通し、地域別動向、および参入企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 市場概要

  • イントロダクション
  • 市場セグメンテーション
  • 市場動向
    • 市場促進因子
    • 市場阻害因子
    • 機会
    • 動向

第6章 業界動向

  • イントロダクション
  • 業界動向
  • ポーターズファイブフォース分析
  • 戦略的ベンチマーキング
  • サプライチェーン分析

第7章 臨床化学分析装置市場:製品別

  • イントロダクション
  • 分析装置
  • 試薬
  • その他の製品

第8章 臨床化学分析装置市場:検査別

  • イントロダクション
  • 基礎代謝
  • 電解質
  • 肝臓
  • 脂質
  • 腎臓
  • 甲状腺機能
  • 特殊化学物質

第9章 臨床化学分析装置市場:エンドユーザー別

  • イントロダクション
  • 学術研究センター
  • 診断試験所
  • 病院
  • その他のユーザー

第10章 地域別分析

  • イントロダクション
  • 南北アメリカ
  • BRIC諸国
  • 欧州
  • 日本
  • その他

第11章 競合環境

  • 概要
  • 市場シェア分析
  • 競合動向
    • 新製品上市
    • 買収
    • 協定、連携、提携
    • 拡大
    • その他の開発

第12章 企業プロファイル

  • イントロダクション
  • Abbott Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Siemens AG
  • Elitech Group
  • 株式会社堀場製作所
  • Mindray Medical International Limited
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.

第13章 付録

目次
Product Code: MD 2843

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global clinical chemistry analyzers market and its subsegments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of the market players. Estimates of their clinical chemistry analyzers segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in the growth rates.

The global clinical chemistry analyzers market report segments this market on the basis of products, test, end users and regions. The clinical chemistry analyzers segment is further divided into four subsegments, Small (400-800 Test/H), Medium (800-1,200 Tests/H), Large (1,200-2,000 Tests/H), and Very large (2,000 Tests/H). The reagent segment is categorized into calibrators, controls, standards and other reagents. The test segments included in this report are basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile/kidney function panel, thyroid function panel, specialty chemical tests.

The geographic segments included in this report are Americas, Europe, BRIC, Japan and Rest of the World (RoW). The geographic analysis reveals that Americas accounted for the largest share in the global clinical chemistry analyzers market in 2014. The BRIC regional segment, on the other hand, is expected to register a faster growth from 2014 to 2019, due to the increasing demand for automation from this region.

The key drivers for this market are rise in number of lifestyle diseases; automation of laboratories will aid the growth of this market. Increasing awareness for preventative care, increase in aging population, increase in reagent rental agreements and laboratory automation will drive the demand for clinical chemistry analyzers products. Growth in the clinical chemistry market will drive the growth of the clinical chemistry analyzers market.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps the market sizes and growth rates of each subsegment and identifies the segments poised for rapid growth in each of the geographic segments. The report also includes company profiles of the market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the clinical chemistry analyzers market. The competitive landscape covers the growth strategies adopted by the industry players over the last three years. It also includes analysis of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development/Innovation: Product portfolios of the top players in the clinical chemistry analyzers market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the clinical chemistry analyzers market
  • Competitive Assessment: In-depth assessment of the market shares, strategies, geographic and business segments, and product portfolios of the leading players in the clinical chemistry analyzers market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various clinical chemistry analyzers products across geographies.
  • Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the clinical chemistry analyzers market.

Table of Contents

1. Introduction

  • 1.1. Objectives Of The Study
  • 1.2. Market Scope
    • 1.2.1. Markets Covered
  • 1.3. Stakeholders

2. Research Methodology

  • 2.1. Market Size Estimation
  • 2.2. Market Crackdown And Data Triangulation
  • 2.3. Market Share Estimation
    • 2.3.1. Key Data From Secondary Sources
    • 2.3.2. Key Data From Primary Sources
      • 2.3.2.1. Key Industry Insights
    • 2.3.3. Assumptions

3. Executive Summary

4. Premium Insights

  • 4.1. Market To Grow At A Modest Rate
  • 4.2. Life Cycle Analysis, By Region

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. Clinical Chemistry Analyzer Market, By Product
    • 5.2.2. Clinical Chemistry Analyzer Market, By Test
    • 5.2.3. Clinical Chemistry Analyzer Market, By End User
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. Increasing Healthcare Expenditure
      • 5.3.1.2. Rapidly Aging Population Is An Important Indirect Driver For This Market
      • 5.3.1.3. Increasing Prevalence Of Lifestyle Diseases
      • 5.3.1.4. Increase In Laboratory Automation
      • 5.3.1.5. Rise In The Number Of Reagent Rental Agreements
      • 5.3.1.6. Increase In Access To Medical Insurance In The U.S. Market
    • 5.3.2. Restraints
      • 5.3.2.1. Requirement Of High Capital Investments
      • 5.3.2.2. Stringent Regulatory Policies For Medical Devices
      • 5.3.2.3. High Degree Of Consolidation To Act As An Entry Barrier For New Entrants
    • 5.3.3. Opportunities
      • 5.3.3.1. Growing Opportunities In Emerging Economies
    • 5.3.4. Trends
      • 5.3.4.1. Quick Turnaround Times
      • 5.3.4.2. High Throughput
      • 5.3.4.3. Demand For Modular Automation

6. Industry Insights

  • 6.1. Introduction
  • 6.2. Porter's Five Forces Analysis
    • 6.2.1. Threat From New Entrants
    • 6.2.2. Threat From Substitutes
    • 6.2.3. Bargaining Power Of Buyers
    • 6.2.4. Bargaining Power Of Suppliers
    • 6.2.5. Competitive Rivalry Among Existing Players
  • 6.3. Strategic Benchmarking
    • 6.3.1. New Product Launches
  • 6.4. Supply Chain Analysis
    • 6.4.1. Key Influencers

7. Clinical Chemistry Analyzers Market, By Product

  • 7.1. Introduction
  • 7.2. Analyzers
  • 7.3. Reagents
  • 7.4. Other Products

8. Clinical Chemistry Analyzers Market, By Test

  • 8.1. Introduction
  • 8.2. Basic Metabolic Panels
  • 8.3. Electrolyte Panels
  • 8.4. Liver Panels
  • 8.5. Lipid Profiles
  • 8.6. Renal Profiles
  • 8.7. Thyroid Function Panels
  • 8.8. Specialty Chemical Tests

9. Clinical Chemistry Analyzers Market, By End Users

  • 9.1. Introduction
  • 9.2. Academic Research Centers
  • 9.3. Diagnostic Laboratories
  • 9.4. Hospitals
  • 9.5. Other End Users

10. Geographic Analysis

  • 10.1. Introduction
  • 10.2. The Americas
    • 10.2.1. Canada
    • 10.2.2. Chile
    • 10.2.3. Mexico
    • 10.2.4. U.S.
    • 10.2.5. Rest Of The Americas (RoA)
  • 10.3. BRIC
    • 10.3.1. Brazil
    • 10.3.2. China
    • 10.3.3. India
    • 10.3.4. Russia
  • 10.4. Europe
    • 10.4.1. France
    • 10.4.2. Germany
    • 10.4.3. Italy
    • 10.4.4. Spain
    • 10.4.5. U.K.
    • 10.4.6. Rest Of Europe (RoE)
  • 10.5. Japan
  • 10.6. Rest Of The World (RoW)

11. Competitive Landscape

  • 11.1. Introduction
  • 11.2. Market Share Analysis
  • 11.3. Competitive Situation And Trends
    • 11.3.1. New Product Launches
    • 11.3.2. Acquisitions
    • 11.3.3. Agreements, Partnerships, And Collaborations
    • 11.3.4. Expansions
    • 11.3.5. Other Developments

12. Company Profiles

  • 12.1. Introduction
  • 12.2. Abbott Laboratories
  • 12.3. Danaher Corporation
  • 12.4. F. Hoffmann-La Roche Ltd.
  • 12.5. Johnson & Johnson
  • 12.6. Siemens AG
  • 12.7. Elitech Group
  • 12.8. Horiba, Ltd.
  • 12.9. Mindray Medical International Limited
  • 12.10. Randox Laboratories Ltd.
  • 12.11. Thermo Fisher Scientific Inc.

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

13. Appendix

  • 13.1. Insights Of Industry Experts
  • 13.2. Discussion Guide
  • 13.3. Introducing Rt: Real-Time Market Intelligence
  • 13.4. Available Customizations
  • 13.5. Related Reports

List of Tables

  • Table 1: Market Developments Between 2011 And 2014
  • Table 2: Global Clinical Chemistry Market Size, By Product, 2012-2019 ($Million)
  • Table 3: Clinical Chemistry Analyzers Market Size, By Capacity, 2012-2019 ($Million)
  • Table 4: Clinical Chemistry Analyzer Market Size, By Region, 2012-2019 ($Million)
  • Table 5: Clinical Chemistry Analyzer Market Size, By Test, 2012-2019 ($Million)
  • Table 6: Basic Metabolic Panel Tests Market Size, By Region, 2012-2019 ($Million)
  • Table 7: Electrolyte Panel Tests Market Size, By Region, 2012-2019 ($Million)
  • Table 8: Liver Panel Tests Market Size, By Region, 2012-2019 ($Million)
  • Table 9: Lipid Profile Tests Market Size, By Region, 2012-2019 ($Million)
  • Table 10: Renal Profile Tests Market Size, By Region, 2012-2019 ($Million)
  • Table 11: Thyroid Function Panel Tests Market Size, By Region, 2012-2019 ($Million)
  • Table 12: Specialty Chemical Tests Market Size, By Region, 2012-2019 ($Million)
  • Table 13: Clinical Chemistry Analyzer Market, By End User, 2012-2019 ($Million)
  • Table 14: Global Clinical Chemistry Market For Academic Research Institutes, By Region, 2012-2019 ($Million)
  • Table 15: Clinical Chemistry Analyzer Market For Diagnostic Laboratories, By Region, 2012-2019 ($Million)
  • Table 16: Global Clinical Chemistry Market For Hospitals, By Region, 2012-2019 ($Million)
  • Table 17: Global Clinical Chemistry Market For Other End Users, By Region, 2012-2019 ($Million)
  • Table 18: Clinical Chemistry Analyzers Market Size, By Region, 2012-2019 ($Million)
  • Table 19: The Americas: Clinical Chemistry Analyzer Market Size, By Country, 2012-2019 ($Million)
  • Table 20: The Americas: Market Size, By Product, 2012-2019 ($Million)
  • Table 21: The Americas: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 22: The Americas: Market Size, By Test, 2012-2019 ($Million)
  • Table 23: The Americas: Market Size, By End User, 2012-2019 ($Million)
  • Table 24: Canada: Clinical Chemistry Analyzer Market Size, By Product, 2012-2019 ($Million)
  • Table 25: Canada: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 26: Chile: Market Size, By Product, 2012-2019 ($Million)
  • Table 27: Chile: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 28: Mexico: Market Size, By Product, 2012-2019 ($Million)
  • Table 29: Mexico: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 30: U.S.: Market Size, By Product, 2012-2019 ($Million)
  • Table 31: U.S.: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 32: RoA: Clinical Chemistry Analyzer Market Size, By Product, 2012-2019 ($Million)
  • Table 33: RoA: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 34: BRIC: Market Size, By Country, 2012-2019 ($Million)
  • Table 35: BRIC: Market Size, By Product, 2012-2019 ($Million)
  • Table 36: BRIC: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 37: BRIC: Market Size, By Test, 2012-2019 ($Million)
  • Table 38: BRIC: Market Size, By End User, 2012-2019 ($Million)
  • Table 39: Brazil: Market Size, By Product, 2012-2019 ($Million)
  • Table 40: Brazil: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 41: China: Market Size, By Product, 2012-2019 ($Million)
  • Table 42: China: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 43: India: Market Size, By Product, 2012-2019 ($Million)
  • Table 44: India: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 45: Russia: Market Size, By Product, 2012-2019 ($Million)
  • Table 46: Russia: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 47: Europe: Market Size, By Region, 2012-2019 ($Million)
  • Table 48: Europe: Market Size, By Product, 2012-2019 ($Million)
  • Table 49: Europe: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 50: Europe: Market Size, By Test, 2012-2019 ($Million)
  • Table 51: Europe: Market Size, By End User, 2012-2019 ($Million)
  • Table 52: France: Market Size, By Product, 2012-2019 ($Million)
  • Table 53: France: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 54: Germany: Market Size, By Product, 2012-2019 ($Million)
  • Table 55: Germany: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 56: Italy: Market Size, By Product, 2012-2019 ($Million)
  • Table 57: Italy: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 58: Spain: Market Size, By Product, 2012-2019 ($Million)
  • Table 59: Spain: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 60: U.K.: Market Size, By Product, 2012-2019 ($Million)
  • Table 61: U.K.: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 62: RoE: Market Size, By Product, 2012-2019 ($Million)
  • Table 63: RoE: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 64: Japan: Market Size, By Product, 2012-2019 ($Million)
  • Table 65: Japan: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 66: Japan: Market Size, By Test, 2012-2019 ($Million)
  • Table 67: Japan: Market Size, By End User, 2012-2019 ($Million)
  • Table 68: RoW: Market Size, By Product, 2012-2019 ($Million)
  • Table 69: RoW: Market Size, By Capacity, 2012-2019 ($Million)
  • Table 70: RoW: Market Size, By Test, 2012-2019 ($Million)
  • Table 71: RoW: Market Size, By End User, 2012-2019 ($Million)
  • Table 72: New Product Launches, 2011-2014
  • Table 73: Acquisitions, 2011-2014
  • Table 74: Agreements, Partnerships, And Collaborations, 2011-2014
  • Table 75: Expansions, 2011-2014
  • Table 76: Other Developments, 2011-2014

List of Figures

  • Figure 1: Global Clinical Chemistry Analyzer Market
  • Figure 2: Research Methodology
  • Figure 3: Market Size Estimation Methodology: Bottom-Up Approach
  • Figure 4: Market Size Estimation Methodology: Top-Down Approach
  • Figure 5: Breakdown Of Primary Interviews: By Company Type, Designation, And Region
  • Figure 6: Data Triangulation Methodology
  • Figure 7: Reagents Is The Largest And Fastest-Growing Product Segment
  • Figure 8: Basic Metabolic Panel Is The Largest Test Segment In 2014
  • Figure 9: Hospitals Will Dominate The Clinical Chemistry Analyzer Market By 2019 30
  • Figure 10: BRIC Is The Fastest-Growing Region In The Clinical Chemistry Analyzer Market
  • Figure 11: Increasing Healthcare Expenditure And Rising Demand From BRIC Are Important Growth Drivers
  • Figure 12: Reagents To Account For The Maximum Market Share In The Clinical Chemistry Analyzer Market
  • Figure 13: BRIC To Grow At The Highest Rate During The Forecast Period
  • Figure 14: BRIC Market Showcases Lucrative Growth Opportunities
  • Figure 15: Market Segmentation: By Product
  • Figure 16: Market Segmentation: By Test
  • Figure 17: Market Segmentation: By End User
  • Figure 18: Increase In Healthcare Expenditure Will Be The Primary Growth Driver In This Market
  • Figure 19: Increasing Healthcare Expenditure Is The Most Important Driver For The Clinical Chemistry Analyzer Market
  • Figure 20: Population Of People Over 65 Years Is Increasing At Close To Twice The Rate Of The General Population
  • Figure 21: Growth In Healthcare Expenditure In BRIC And RoW Outpacing That In Americas And Europe
  • Figure 22: Porter's Five Forces Analysis
  • Figure 23: Most Market Players Adopted Organic Growth Strategy Of New Product Launches Between 2011 And 2014
  • Figure 24: Supply Chain Analysis
  • Figure 25: Clinical Chemistry Analyzer Market, By Product
  • Figure 26: Market Share, By Product, 2012-2019
  • Figure 27: Market Segmentation, By Capacity
  • Figure 28: Clinical Chemistry Analyzer Market Size, By Capacity, 2012-2019 ($Million)
  • Figure 29: Clinical Chemistry Reagents Market Size, By Region, 2012-2019 ($Million)
  • Figure 30: Clinical Chemistry Reagents Market Size, By Region, 2012-2019 ($Million)
  • Figure 31: Clinical Chemistry Other Products Market Size, By Region, 2012-2019 ($Million)
  • Figure 32: Clinical Chemistry Other Products Market Size, By Region, 2012-2019 ($Million)
  • Figure 33: Clinical Chemistry Analyzer Market, By Test
  • Figure 34: Clinical Chemistry Analyzer Market Size, By Test, 2014 (Market Size And Growth Rates)
  • Figure 35: Americas To Account For The Largest Share In The Basic Metabolic Panel Segment
  • Figure 36: Americas To Account For The Largest Share Of The Electrolyte Panel Test Segment
  • Figure 37: BRIC To Grow At The Highest CAGR In The Liver Panel Tests Market
  • Figure 38: Increased Obesity Rates To Aid The Growth Of The Lipid Profile Tests Segment
  • Figure 39: BRIC To Be The Fastest-Growing Market For Lipid Profile Tests
  • Figure 40: BRIC Is Expected To Be The Fastest-Growing Market For Renal Profile Tests
  • Figure 41: Americas Is The Largest Market For Thyroid Function Panel Tests
  • Figure 42: Americas Are The Largest Market For Specialty Chemical Tests
  • Figure 43: Clinical Chemistry Analyzer Market, By End User
  • Figure 44: Clinical Chemistry Analyzer Market Size, By End User, 2014 (Market Size And Growth Rates)
  • Figure 45: America Holds Largest Share Of Clinical Chemistry Analyzer Market For Academic Research Institutes
  • Figure 46: The Americas Holds Largest Share Of Clinical Chemistry Analyzer Market For Diagnostic Laboratories
  • Figure 47: BRIC Hospitals Segment Expected To Show Fastest Growth In Clinical Chemistry Analyzer Market
  • Figure 48: BRIC Regional Segment Shows Highest Growth In Clinical Chemistry Analyzer Market For Other End Users
  • Figure 49: Clinical Chemistry Analyzer Market, By Region
  • Figure 50: Global Economic Indicators (2003-2012)
  • Figure 51: Clinical Chemistry Analyzer Market, By Region (Market Size And Growth Rate), 2014-2019
  • Figure 52: Americas: Economic Indicators (2003-2012)
  • Figure 53: Americas: Market Snapshot
  • Figure 54: Americas: Clinical Chemistry Analyzer Market, By Region (Market Size And Growth Rate), 2014-2019
  • Figure 55: Reagents Are Estimated To Be The Largest Product Segment In The Americas In 2014
  • Figure 56: The Americas: Medium-Sized Analyzers To Grow At The Highest CAGR From 2014 To 2019
  • Figure 57: The Americas: Clinical Chemistry Market Size, By Test (Market Size And Growth Rate), 2014-2019
  • Figure 58: Hospitals To Account For The Largest Share Of The Clinical Chemistry Analyzers End-Users Market In The Americas
  • Figure 59: Canada: Economic Indicators (2003-2012)
  • Figure 60: Reagents Are The Largest And The Fastest-Growing Product Segment In Canada- 2014-2019
  • Figure 61: Small-Sized Analyzers To Be The Fastest-Growing Analyzers Segment In Canada- 2014-2019
  • Figure 62: Chile: Economic Indicators (2003-2012)
  • Figure 63: Reagents To Account For The Largest Share Of The Clinical Chemistry Market In Chile- 2014-2019
  • Figure 64: Chile: Small-Sized Analyzers To Grow At Highest CAGR From 2014-2019
  • Figure 65: Mexico: Economic Indicators (2003-2012)
  • Figure 66: Reagents To Be The Fastest-Growing Product Segment In Mexico
  • Figure 67: Mexico: Small-Sized Analyzers To Witness The Highest Growth
  • Figure 68: U.S.: Economic Indicators (2003-2012)
  • Figure 69: Reagents Are The Largest Product Segment In The U.S.
  • Figure 70: U.S.: Medium-Sized Analyzers To Witness Highest Growth
  • Figure 71: RoA: Economic Indicators (2003-2012)
  • Figure 72: Reagents To Be The Fastest-Growing Product Segment In The RoA
  • Figure 73: RoA: Small-Sized Analyzers To Grow At Highest CAGR
  • Figure 74: BRIC: Economic Indicators (2003-2012)
  • Figure 75: BRIC: Clinical Chemistry Analyzers Market, By Country (Market Size And Growth Rate), 2014-2019
  • Figure 76: Reagents To Account For The Largest Share Of The Clinical Chemistry Analyzers Market In BRIC In 2014
  • Figure 77: BRIC: Small-Sized Analyzers To Witness Highest CAGR
  • Figure 78: Lipid Profile Is The Fastest-Growing Test Segment In BRIC Between 2014 And 2019
  • Figure 79: Hospitals Are The Largest And The Fastest-Growing End-User Segment In BRIC
  • Figure 80: Brazil: Economic Indicators (2003-2012)
  • Figure 81: Brazil: The Reagents Segment To Witness Highest Growth
  • Figure 82: Brazil: Small-Sized Analyzers To Grow At The Highest CAGR
  • Figure 83: China: Economic Indicators (2003-2012)
  • Figure 84: Reagents Are The Largest Product Segment In China
  • Figure 85: China: Small-Sized Analyzers To Grow At The Highest CAGR
  • Figure 86: India: Economic Indicators (2003-2012)
  • Figure 87: Reagents Are The Largest And The Fastest-Growing Product Segment In India
  • Figure 88: India: Small-Sized Analyzers To Witness Highest Growth
  • Figure 89: Russia: Economic Indicators (2003-2012)
  • Figure 90: Reagents To Be The Fastest-Growing Product Segment In Russia
  • Figure 91: Small-Sized Analyzers To Be The Fastest-Growing Analyzer Segment In Russia
  • Figure 92: Europe: Economic Indicators (2003-2012)
  • Figure 93: Europe: Market Snapshot
  • Figure 94: Europe: Clinical Chemistry Analyzer Market, By Region, 2014-2019 (Market Size And Growth Rates)
  • Figure 95: Reagents Are The Largest Revenue Contributors To Clinical Chemistry Analyzer Market In Europe In 2014
  • Figure 96: Medium-Sized Analyzers To Hold Largest Market Share In Europe
  • Figure 97: Lipid Profile To Be Fastest-Growing Test Segment Of Clinical Chemistry Analyzers Market In Europe
  • Figure 98: Hospitals To Hold Largest Market Share In Europe
  • Figure 99: France: Economic Indicators (2003-2012)
  • Figure 100: Reagents To Witness Highest Growth In France By 2019
  • Figure 101: Medium-Sized Analyzers Market To Witness Highest Growth
  • Figure 102: Germany: Economic Indicators (2003-2012)
  • Figure 103: Reagents To Witness Highest Growth Rate In Germany By 2019
  • Figure 104: Medium-Sized Analyzers Segment To Witness Highest Growth
  • Figure 105: Italy: Economic Indicators (2003-2012)
  • Figure 106: Reagents To Witness Highest Growth Rate In Italy By 2019
  • Figure 107: Small-Sized Analyzers To Be The Fastest-Growing Analyzers Segment In Italy
  • Figure 108: Spain: Economic Indicators (2003-2012)
  • Figure 109: Reagents To Witness Highest Growth Rate In Spain By 2019
  • Figure 110: Small-Sized Analyzers To Be The Fastest-Growing Analyzers Segment In Spain
  • Figure 111: U.K.: Economic Indicators (2003-2012)
  • Figure 112: Reagents To Witness Highest Growth Rate In The U.K. By 2019
  • Figure 113: Medium-Sized Analyzers To Be The Fastest-Growing Analyzers Segment In The U.K.
  • Figure 114: RoE: Economic Indicators (2003-2012)
  • Figure 115: Reagents To Witness Highest Growth Rate In RoE By 2019
  • Figure 116: Small-Sized Analyzers To Be Fastest-Growing Segment In RoE
  • Figure 117: Japan: Economic Indicators (2003-2012)
  • Figure 118: Reagents Are Estimated To Command Largest Share Of The Total Clinical Chemistry Analyzer Market In Japan In 2014
  • Figure 119: Medium-Sized Analyzers To Command Largest Market Share In Japan
  • Figure 120: Lipid Profiles To Be The Fastest-Growing Test Segment In Clinical Chemistry Analyzer Market In Japan
  • Figure 121: Hospitals To Command Largest Share Of End-User Market In Japan
  • Figure 122: RoW: Economic Indicators (2003-2012)
  • Figure 123: Reagents Command Largest Share Of Total Clinical Chemistry Analyzers Market In The RoW
  • Figure 124: Medium-Size Analyzers To Hold Largest Share In Europe
  • Figure 125: Lipid Profiles To Be The Fastest-Growing Test Segment In RoW
  • Figure 126: Hospitals To Command Largest Share Of End-User Market In RoW
  • Figure 127: Product Innovations Is The Key Strategy Adopted By Players In The Clinical Chemistry Analyzers Market
  • Figure 128: Market Share Analysis, By Key Player, 2014
  • Figure 129: New Product Launches Is The Key Growth Strategy
  • Figure 130: Geographic Revenue Mix Of Top 5 Market Players
  • Figure 131: Abbott Laboratories: Business Overview
  • Figure 132: Danaher Corporation: Business Overview
  • Figure 133: F. Hoffmann-La Roche Ltd.: Business Overview
  • Figure 134: Johnson & Johnson: Business Overview
  • Figure 135: Siemens AG: Business Overview
  • Figure 136: Horiba, Ltd.: Business Overview
  • Figure 137: Mindray Medical International Limited: Business Overview
  • Figure 138: Thermo Fisher Scientific Inc.: Business Overview
Back to Top